NUP210 and primary biliary cholangitis: Since 2017, anti-gp210, which targets one of the constitutive proteins od the nuclear pore complex, has emerged as a diagnostic marker for AMA-negative PBC, increasing the diagnostic rate and preventing some patients from undergoing needless liver biopsies [61].